Search Results - "Lauritsen, Clinton"

  • Showing 1 - 18 results of 18
Refine Results
  1. 1

    CGRP Monoclonal Antibodies for Migraine: Rationale and Progress by Yuan, Hsiangkuo, Lauritsen, Clinton G., Kaiser, Eric A., Silberstein, Stephen D.

    “…Calcitonin gene-related peptide (CGRP), a neuropeptide abundant in the trigeminal system and widely expressed in both the peripheral and central nervous…”
    Get full text
    Journal Article
  2. 2

    Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis by Yuan, Hsiangkuo, Natekar, Aniket, Park, Jade, Lauritsen, Clinton G, Viscusi, Eugene R, Marmura, Michael J

    Published in Regional anesthesia and pain medicine (01-12-2023)
    “…IntroductionSubanesthetic ketamine infusion has been used for managing refractory headache in inpatient or outpatient infusion settings. Intranasal ketamine…”
    Get full text
    Journal Article
  3. 3

    Lidocaine infusions for refractory chronic migraine: a retrospective analysis by Schwenk, Eric S, Walter, Aaron, Torjman, Marc C, Mukhtar, Sarah, Patel, Harsh T, Nardone, Bryan, Sun, George, Thota, Bhavana, Lauritsen, Clinton G, Silberstein, Stephen D

    Published in Regional anesthesia and pain medicine (01-07-2022)
    “…IntroductionPatients with refractory chronic migraine have poor quality of life. Intravenous infusions are indicated to rapidly ‘break the cycle’ of pain…”
    Get full text
    Journal Article
  4. 4

    Current Treatment Options: Vestibular Migraine by Lauritsen, Clinton G., Marmura, Michael J.

    Published in Current treatment options in neurology (01-11-2017)
    “…Opinion statement Vestibular migraine (VM) is a disorder with a spectrum of clinical presentations and among the most common causes of chronic vestibular…”
    Get full text
    Journal Article
  5. 5

    Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine by Mojica, Jeffrey J., Schwenk, Eric S., Lauritsen, Clinton, Nahas, Stephanie J.

    Published in Current pain and headache reports (01-12-2021)
    “…Purpose of Review The purpose of this review is to discuss the available evidence and therapeutic considerations for intravenous drug therapy for refractory…”
    Get full text
    Journal Article
  6. 6

    Central Nervous System Involvement of Multiple Myeloma Presenting as Short-lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing: A Case Report by Wang, Victor S., Ahmad, Ayesha, Mazuera, Santiago, Lauritsen, Clinton G.

    Published in Neurohospitalist (01-07-2022)
    “…Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache attacks with…”
    Get full text
    Journal Article
  7. 7

    Current Treatment Options: Headache Related to Menopause—Diagnosis and Management by Lauritsen, Clinton G., Chua, Abigail L., Nahas, Stephanie J.

    Published in Current treatment options in neurology (01-04-2018)
    “…Purpose of review Menopause is a life-changing event in numerous ways. Many women with migraine hold hope that the transition to the climacteric state will…”
    Get full text
    Journal Article
  8. 8

    Ketamine for Refractory Headache: A Retrospective Analysis by Schwenk, Eric S, Dayan, Amir C, Rangavajjula, Ashwin, Torjman, Marc C, Hernandez, Mauricio G, Lauritsen, Clinton G, Silberstein, Stephen D, Young, William, Viscusi, Eugene R

    Published in Regional anesthesia and pain medicine (01-11-2018)
    “…BACKGROUND AND OBJECTIVESThe burden of chronic headache disorders in the United States is substantial. Some patients are treatment refractory. Ketamine, an…”
    Get full text
    Journal Article
  9. 9

    DHE-Induced Peripheral Arterial Vasospasm in Primary Raynaud Phenomenon: Case Report by Khalife, Jane, Lauritsen, Clinton G., Liang, John, Shah, Syed O.

    Published in Neurohospitalist (01-04-2019)
    “…Dihydroergotamine (DHE) is primarily a serotonin 5HT1B and 5HT1D receptor agonist used for acute migraine treatment. It is associated with acute…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study by Wang, Victor S., Kosman, Justin, Yuan, Hsiangkuo, Lauritsen, Clinton, Shrewsbury, Stephen, Aurora, Sheena K., Hopkins, Mary, Silberstein, Stephen

    Published in Headache (01-10-2023)
    “…BackgroundDihydroergotamine (DHE), like triptans, is contraindicated in patients with ischemic heart disease or coronary vasospasm. Its true safety,…”
    Get full text
    Journal Article
  14. 14

    Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series by Lauritsen, Clinton, Mazuera, Santiago, Lipton, Richard B., Ashina, Sait

    Published in Journal of headache and pain (01-12-2016)
    “…Background Refractory migraine is a challenging condition with great impact on health related quality of life. Intravenous (IV) ketamine has been previously…”
    Get full text
    Journal Article
  15. 15

    Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis by Schwenk, Eric S., Torjman, Marc C., Moaddel, Ruin, Lovett, Jacqueline, Katz, Daniel, Denk, William, Lauritsen, Clinton, Silberstein, Stephen D., Wainer, Irving W.

    Published in Journal of clinical pharmacology (01-11-2021)
    “…Patients with refractory chronic migraine have substantial disability and have failed many acute and preventive medications. When aggressive intravenous…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18